Epirubicin HCl【D】

Antineoplastic Agents: Cytotoxic Agents: Antitumor Antibiotics
IEPIC1 “Epicin injection” 2 mg/ml; 10 ml/vial
IEPIC3 “Epicin Lyo injection” 10 ml/vial

適應症:乳腺癌、惡性淋巴瘤、軟組織肉瘤、胃癌、肺癌、卵巢瘤。

Usual dose:

Breast cancer, adjuvant therapy: initial starting dose, 100-120 mg/m2 IV given q3-4w; then, 60 mg/m2 IV on Day-1 and Day-8 repeated q28d for 6 cycles in combination with cyclophosphamide and 5-fluorouracil, max. total cumulative dose 900 mg/m2.

Cancers, others: usual dose range 60-120 mg/m2 q21-28d in combination with other agents, max. total cumulative dose 900 mg/m2.

Precaution:

P’ts receiving 120 mg/m2 regimens should be administered prophylactic antibiotics with trimethoprim-sulfamethoxazole or a fluoroquinolone.

Adverse effect:

Alopecia, rash, skin changes, radiation-recall reactions, amenorrhea, hot flashes, fever, infection, lethargy, N/V, diarrhea, mucositis.

Related Entries

(Visited 13 times, 1 visits today)